We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4118:TSEKaneka Corporation Analysis

Data as of 2026-06-12 - not real-time

¥5,549.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Kaneka’s share price of ¥5,549 sits comfortably above its 20‑day (¥5,426), 50‑day (¥5,165) and 200‑day (¥4,670) moving averages, underscoring a bullish price trend. RSI at 63.8 confirms momentum is still positive, though the MACD histogram of –11.9 and a bearish MACD signal warn of potential short‑term weakening as the stock approaches its 52‑week resistance near ¥5,658. Valuation metrics are attractive – a trailing PE of 11.1 and PB of 0.68 are well below industry averages, while the discounted cash‑flow model suggests a fair value around ¥6,228, indicating the stock is currently undervalued. The dividend yield of 3.85% with a modest payout ratio of 32% appears sustainable given positive operating cash flow despite a small negative free cash flow. Fundamentals show modest revenue growth of 4.5% and thin margins (gross 27.8%, operating 4.4%, profit 3.8%), with ROE at 6.4% and a high debt‑to‑equity of 44.3%, though the company maintains ample cash and a low beta of 0.30, reflecting limited price volatility. Overall, the stock presents a mixed technical picture but solid long‑term fundamentals, a generous dividend, and room for price appreciation, supporting a buy stance for medium to long horizons while recommending a cautious hold in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near 52‑week resistance
  • Bearish MACD signal
  • Strong dividend yield

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued multiples (PE, PB)
  • Sustainable dividend and cash flow
  • Potential upside toward DCF fair value

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Low beta and modest volatility
  • Diversified specialty chemicals portfolio
  • Consistent dividend policy

Key Metrics & Analysis

Financial Health

Revenue Growth4.50%
Profit Margin3.82%
P/E Ratio11.1
ROE6.43%
ROA2.10%
Debt/Equity44.34
P/B Ratio0.7
Op. Cash Flow¥50.1B
Free Cash Flow¥-2630749952

Technical Analysis

TrendBullish
RSI63.8
Support¥5,210.00
Resistance¥5,658.00
MA 20¥5,426.40
MA 50¥5,164.50
MA 200¥4,669.77
MACDBearish
VolumeStable
Fear & Greed Index86.71

Valuation

Fair Value¥6,227.98
Target Price¥4,966.67
Upside/Downside-10.49%
GradeUndervalued
TypeBlend
Dividend Yield3.85%

Risk Assessment

Beta0.30
Volatility22.71%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.